Abstract 10P
Background
Non-coding RNAs (ncRNAs) have emerged as a significant theranostic agents in Breast Cancer (BC). These ncRNAs including microRNAs (miRNAs) play a fundamental role in regulating BC hallmarks and hold significant potential as diagnostic and prognostic biomarkers and therapeutic agents for non-metastatic BC thus perfectly fulfill the definition of theranostic agents. Moreover, ncRNAs offer advantages over traditional biomarkers as they provide greater accuracy and are less invasive nature. miR-1275 and miR-4317 have been reported by our group to act as tumor suppressor miRNAs in BC through repressing cellular migration, invasion and clonogenicity. However, miR-96 and miR-744 were spotted as aggressive oncomiRs in BC activating several oncogenic pathways. The aim of this study was to investigate the expression patterns of the aforementioned miRNAs in BC patients and to assess their role as theranostic agents through assessing their association with different clinical parameters.
Methods
BC patients (n=30) were recruited. BC tumors and their normal counterparts were resected. BC patients ‘age range (25-70 years old). Lymph node involvement, tumor grade, molecular subtype, ki-67 levels and PD-L1 surface expression were evaluated in all patients included in the study. RNA was extracted from biopsies, reverse transcribed and quantified using q-RT-PCR.
Results
OncomiRs: miR-744 and miR-96 were found to be overexpressed in BC tissues compared to their normal counterparts. While the tumor suppressor miRNAs: miR-1275 and miR-4317 was found to de downregulated in BC tissues. Upon assessing BC patients’ clinical parameter, it was found that miR-744 and miR-96 expression levels are correlated with high tumor grade (53%), positive lymphnode metastasis (63.3%). On the other hand, miR-1275 and miR-4317 reduced expression levels were found to be associated with PDL1+TNBC patients (60%). Yet, miR-744, miR-96 and miR-1275 levels were found to be higher in young BC patients.
Conclusions
This study highlights the involvement of paradoxically acting miRNAs in the differential diagnosis of BC subtypes and highlights their high prognostic potential. Moreover, it identifies the studied panel of miRNAs as novel theranostic agents in BC.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
L'Oréal-UNESCO For Women in Science.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
61P - Unveiling the distinctive molecular, clinical, and prognostic features of infant acute myeloid leukemia: An analysis study of pediatric AML datasets from the Children's Oncology Group
Presenter: YU TAO
Session: Cocktail & Poster Display session
Resources:
Abstract
62P - Nomogram for predicting lung metastases in patients with papillary thyroid cancer under 55 years old
Presenter: Huiyun Yang
Session: Cocktail & Poster Display session
Resources:
Abstract
64P - Evaluating gene alterations associated with recurrence in oral cavity squamous cell carcinoma
Presenter: Amanda Reyes
Session: Cocktail & Poster Display session
Resources:
Abstract
65P - Multiplex immunofluorescence analysis of LRRC15 and the TME in early-stage lung adenocarcinoma
Presenter: Jessie Woon
Session: Cocktail & Poster Display session
Resources:
Abstract
66P - Molecular profile of triple-negative breast cancer tumours and their association with response to neoadjuvant treatment: A study using next generation sequencing
Presenter: Juan Ramón Berenguer-Marí
Session: Cocktail & Poster Display session
Resources:
Abstract
67P - Multi-institutional evaluation of interrater agreement of biomarker-drug pair rankings based on the ESMO scale for clinical actionability of molecular targets (ESCAT) and sources of discordance
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract
68P - ESR1 gene mutation in hormone receptor (HR)-positive metastatic breast cancers: An NGS-based exploratory study on Indian population
Presenter: Siddappa Shanthala
Session: Cocktail & Poster Display session
Resources:
Abstract
69P - Next generation sequencing in colorectal cancer: Association of BRAF, KRAS mutations with right sided cancers, mucinous disease, lymphovascular/perineural invasion and microsatellite instability
Presenter: Gurpreet Singh Ranger
Session: Cocktail & Poster Display session
Resources:
Abstract
70P - Increased expression of interleukin-17 receptor A (IL-17RA) promotes cancer stem-like properties, resistance to 5-fluorouracil, and the expression of ATP-binding cassette transporters in colorectal cancer cells
Presenter: Chih-Yung Yang
Session: Cocktail & Poster Display session
Resources:
Abstract
71P - When neighbors play a role: The importance of interacting proteins in the tumorigenic effect of cancer driver genes
Presenter: Margarida Carrolo
Session: Cocktail & Poster Display session
Resources:
Abstract